These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4944409)

  • 1. Relief of anxiety and related emotions in patients with gastrointestinal disorders. A double-blind controlled study.
    Deutsch EM
    Am J Dig Dis; 1971 Dec; 16(12):1091-4. PubMed ID: 4944409
    [No Abstract]   [Full Text] [Related]  

  • 2. [The association of lexotan + propantheline in the treatment of functional gastrointestinal disorders. Controlled clinical study].
    Riva D; Manieri L; Mariano P
    Arch Sci Med (Torino); 1980; 137(3):461-6. PubMed ID: 6112973
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gefarnax in the treatment of gastrointestinal diseases of psychosomatic origin].
    Bianchi A; Scanni A; Giorgi-Conciato M
    Minerva Gastroenterol; 1972; 18(3):175-81. PubMed ID: 4614115
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind study of heteronium bromide and amobarbital in the management of gastrointestinal conditions associated with anxiety.
    Kasich AM
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):508-13. PubMed ID: 4971465
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of the bromazepam-propantheline combination in patients with organic and functional gastrointestinal disorders].
    Laghi-Pasini F
    Clin Ter; 1977 Nov; 83(3):301-11. PubMed ID: 23917
    [No Abstract]   [Full Text] [Related]  

  • 6. [Flupentixol (Fluanxol) or diazepam in the treatment of various psychosomatic conditions. A controlled double-blind multicenter study].
    Damsbo N; Lassen T; Falhof SL
    Ugeskr Laeger; 1986 Dec; 149(1):12-6. PubMed ID: 3544417
    [No Abstract]   [Full Text] [Related]  

  • 7. A double blind trial for the clinical management of psychogenic headache.
    Okasha A; Ghaleb HA; Sadek A
    Br J Psychiatry; 1973 Feb; 122(567):181-3. PubMed ID: 4577014
    [No Abstract]   [Full Text] [Related]  

  • 8. GI illness: treatment of the anxiety component.
    Chaplan A; Vanov SK
    Psychosomatics; 1977 Oct; 18(4):49-54. PubMed ID: 335424
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of psychosomatic gastrointestinal disorders in ambulatory patients].
    De Martino G; Giorgi-Conciato M; Gaudieri V; Caruso D; De Iorio A
    Minerva Med; 1973 Dec; 64(87):4583-95. PubMed ID: 4774226
    [No Abstract]   [Full Text] [Related]  

  • 10. [The gefarnate-diazepam combination in the treatment of various gastrointestinal diseases].
    Vezzadini P; Giorgi-Conciato M; Tomassetti P; Finatti F
    Clin Ter; 1978 May; 85(3):274-9. PubMed ID: 679632
    [No Abstract]   [Full Text] [Related]  

  • 11. [Controlled therapeutic trial of gastroenteric diseases with psychogenic interference].
    Malaguti P
    Minerva Med; 1970 Feb; 61(11):479-84. PubMed ID: 5416957
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of doxepin and diazepam in patients with gastrointestinal disease and anxiety. A controlled double blind study and long-term evaluation.
    Kasich AM
    Psychosomatics; 1969; 10(3):18-20. PubMed ID: 4897562
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of a new benzodiazepine preparation, S-804, for the treatment of psychoneurotic and psychosomatic disorders by double-blind cross-over test].
    Tanaka H; Takayama I; Ookubo N; Yoshimuta S; Kono Y
    Saishin Igaku; 1970 May; 25(5):1128-36. PubMed ID: 4912179
    [No Abstract]   [Full Text] [Related]  

  • 14. [Double-blind study on the activity of RO 10-9618 (bromazepam and propantheline) in organic and functional disturbances of the gastrointestinal apparatus].
    Destito D; Tentori-Montalto T
    Clin Ter; 1976 Jul; 78(1):57-63. PubMed ID: 12905
    [No Abstract]   [Full Text] [Related]  

  • 15. Treating psychical disturbances induced by physical disorders: a double-blind study of perphenazine-amitriptyline in anxiety and depression.
    Davis WG
    Psychosomatics; 1968; 9(1):44-6. PubMed ID: 4867598
    [No Abstract]   [Full Text] [Related]  

  • 16. Chlorazepate dipotassium in the treatment of anxiety associated with chronic gastrointestinal disease.
    Kasich AM
    Curr Ther Res Clin Exp; 1973 Mar; 15(3):83-91. PubMed ID: 4196231
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-blind study of a psychotropic-anticholinergic drug in gastric disorders.
    Cromwell HA
    Med Times; 1968 Sep; 96(9):933-8. PubMed ID: 4876840
    [No Abstract]   [Full Text] [Related]  

  • 18. Application of the neuroleptic pimozide (ORAP-R 6238) for tranquilizer indications in a controlled study.
    Pöldinger W
    Int Pharmacopsychiatry; 1976; 11(1):16-24. PubMed ID: 770363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relief of musculoskeletal and associated psychopathological symptoms with meprobamate and aspirin: a controlled study.
    Gilbert MM; Koepke HH
    Curr Ther Res Clin Exp; 1973 Nov; 15(11):820-32. PubMed ID: 4201595
    [No Abstract]   [Full Text] [Related]  

  • 20. Camazepam versus diazepam: a double-blind trial on psychoneurotic patients.
    Deberdt R
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):32-9. PubMed ID: 237742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.